Correction: Measuring mental wellbeing in clinical and non-clinical adolescents using the COMPAS-W Wellbeing Scale - Summary - MDSpire

Correction: Measuring mental wellbeing in clinical and non-clinical adolescents using the COMPAS-W Wellbeing Scale

  • By

  • Janine R. Lam

  • Haeme R. P. Park

  • Justine M. Gatt

  • May 27, 2026

  • 0 min

Share

Objective:

To correct and clarify details regarding the COMPAS-W Wellbeing Scale used in a study assessing mental wellbeing in adolescents.

Key Findings:
  • The COMPAS-W scale is no longer available for unrestricted use.
  • The correction in the Results section does not affect the original findings of the study.
  • The scale is available for non-commercial academic use and licensed for commercial use.
Interpretation:

The amendment clarifies the usage and rights associated with the COMPAS-W scale.

Limitations:
  • The proprietary nature of the COMPAS-W scale limits its unrestricted availability.
Conclusion:

The article has been updated to reflect these corrections and clarifications.

Original Source(s)

Correction: Measuring mental wellbeing in clinical and non-clinical adolescents using the COMPAS-W Wellbeing Scale

  • by Janine R. Lam, Haeme R. P. Park, Justine M. Gatt

  • May 27, 2026

Related Content

Online Program Eases Pediatric Trauma Stress

Randomized trial evaluated therapist-assisted intervention among pediatric patients with persistent symptoms 1 month following trauma

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.

The Mental Health Gap Doctors Don’t Close

National survey data also suggested lower treatment rates among health care workers with either condition.